Plants offer an alternative to microbial fermentation and animal cell cultures for the
production of recombinant proteins. For protein pharmaceuticals, plant systems are …

Plant systems are reviewed with regard to their ability to express and produce subunit
vaccines. Examples of different types of expression systems producing a variety of vaccine …

Previous clinical studies have demonstrated the feasibility of using edible transgenic plants
to deliver protective antigens as new oral vaccines. Transgenic corn is particularly attractive …

Recombinant plant expression systems offer a means to produce large quantities of selected
antigens for subunit vaccines. Cereals are particularly well-suited expression vehicles since …

The use of recombinant gene technologies by the vaccine industry has revolutionized the
way antigens are generated, and has provided safer, more effective means of protecting …

The induction of mucosal immunity is very important in conferring protection against
pathogens that typically invade via mucosal surfaces. Delivery of a vaccine to a mucosal …

Ethanol from lignocellulosic biomass is being pursued as an alternative to petroleum‐based
transportation fuels. To succeed in this endeavour, efficient digestion of cellulose into …

The synthesis of selected antigens in plants and their oral delivery has great potential for
reducing the costs of vaccine production and administration. The application of this …

Production of recombinant proteins is primarily established in cultures of mammalian, insect
and bacterial cells. Concurrently, concept of using plants to produce high-value …

Transgenic plants have been employed successfully as a low-cost system for the production
of therapeutically valuable proteins, including antibodies, antigens and hormones. Here, we …